Arcutis Accounts Payable from 2010 to 2025
ARQT Stock | USD 13.24 0.43 3.15% |
Accounts Payable | First Reported 2018-12-31 | Previous Quarter 7.9 M | Current Value 19.3 M | Quarterly Volatility 5 M |
Check Arcutis Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers, such as Interest Expense of 35.9 M, Selling General Administrative of 209.5 M or Total Revenue of 72 M, as well as many indicators such as Price To Sales Ratio of 4.1, Dividend Yield of 0.0 or PTB Ratio of 2.39. Arcutis financial statements analysis is a perfect complement when working with Arcutis Biotherapeutics Valuation or Volatility modules.
Arcutis | Accounts Payable |
Latest Arcutis Biotherapeutics' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Arcutis Biotherapeutics over the last few years. An accounting item on the balance sheet that represents Arcutis Biotherapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Arcutis Biotherapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Arcutis Biotherapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
Arcutis Accounts Payable Regression Statistics
Arithmetic Mean | 4,442,821 | |
Geometric Mean | 1,853,590 | |
Coefficient Of Variation | 118.87 | |
Mean Deviation | 4,615,777 | |
Median | 1,405,000 | |
Standard Deviation | 5,281,052 | |
Sample Variance | 27.9T | |
Range | 13.9M | |
R-Value | 0.88 | |
Mean Square Error | 6.5T | |
R-Squared | 0.78 | |
Slope | 980,382 | |
Total Sum of Squares | 418.3T |
Arcutis Accounts Payable History
About Arcutis Biotherapeutics Financial Statements
Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Accounts Payable | 13.8 M | 14.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.